Tumor inhibiting and immunoloregulation effects of Mylabris Mixture on H22 cancer-bearing mice

Journal of Chinese Integrative Medicine

Volumn 4, Issue 5, 2006, Pages 504-508

  Zhou, A Gao ^a   Zhang, Yong ^a   Kong, De Yun ^b   Wang, Yin ^a   Zhang, Hui Zhen ^a   Wang, Shu Jun ^a   Kui, Gang ^a   Hong, Sheng ^a   Ge, Hai Liang ^a   Ren, Qiu Hua ^a   Mao, Xu Ming ^a   Dong, Jia Rong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

Author keywords

Cancer of liver; Immunoloregulation; Mylabris Mixture; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 4; MYLABRIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; HUMORAL IMMUNITY; IMMUNOREGULATION; IMMUNOSTIMULATION; LIVER CANCER; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; OBSERVATIONAL STUDY; RAT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BEETLES; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DRUGS, CHINESE HERBAL; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MATERIA MEDICA; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; T-LYMPHOCYTES;

EID: 33748928280     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20060513     Document Type: Article

References (19)

1. Yang B, Donald M, Chinese source. 2004, 24(5): 422-426.
2. Chinese source. 2005, 11(10): 1414-1414.
3. Chinese source. 2004, 27(12): 844-845.
4. Tsai JP, Chen HW, Cheng ML, et al. Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-beta1 and interleukin-6 in the development of in situ tumor immunity. Immunobiology, 2005, 210(9): 661-671.
5. Chinese source. 2000. 360-363.
6. + T-cell responses in tumor-bearing hosts. Cancer Res, 2005, 65(15): 6984-6989.
7. Chinese source. 2005, 3(5): 374-377.
8. Chinese source. 2002, 9(3): 172-174.
9. Chinese source. 2005, 18(16): 729-730.
10. Shavit Y, Ben-Eliyahu S, Zeidel A, et al. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation, 2004, 11(4): 255-260.
11. Iwasaka H, Noguchi T. Th1/Th2 balance in systemic inflammatory response syndrome (SIRS). Nippon Rinsho, 2004, 62(12): 2237-2243.
12. Ovsvannikova IG, Rvan JE, Vierkant RA, et al. Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics, 2005, 57(11): 828-836.
13. Okamoto M, Hasegawa Y, Hara T, et al. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest, 2005, 128(6): 4030-4035.
14. Chinese source. 2005, 25(3): 205-207.
15. Chinese source. 2005, 16(4): 262-264.
16. Wang GS. Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol, 1989, 26(2): 147-162.
17. Chinese source. 1983. 1113.
18. Chinese source. 2002, 9(6): 336.
19. Chinese source. 2004, 23(6): 385-386.